Emergent Drug Panel and Internal Standard Kits (EDP, EDP-V1, EDP-IS Kits)
The EDP and EDP-V1 Kits contain reference materials that support laboratory screening for 80 emergent synthetic opioids, benzodiazepines, stimulants, hallucinogens, synthetic cannabinoids, and xylazine. The new EDP-Internal Standard (EDP-IS) kit contains 24 isotopically labeled internal standards corresponding to the most prevalent compounds contained in the EDP and FAS Kit panels.
These materials are distributed by Cayman Chemical, an ISO-accredited reference material producer, to labs in the US and its territories. Labs eligible to apply for the EDP, EDP-V1, and EDP-IS kits must have a valid DEA controlled substance registration for Schedule I controlled substances.
Traceable Opioid Material® Kits are reference materials and do not eliminate the need to meet analytical method requirements of other federal agencies or the need to comply with state and local regulations. Traceable Opioid Material® Kits are not for diagnostic use.
Compounds in the EDP Kit
Additional Product Information
- EDP and EDP-V1 Kits include 200 micrograms of each compound
- The EDP-IS Kit includes 200 micrograms of each isotopically labeled compound in a 2 mg/mL solution
- Includes the most prevalent compounds identified on Drug Enforcement Administration (DEA) Emerging Threat Reports and The Center for Forensic Science Research and Education (CFSRE) Scope and Trend Reports (2019-2022)
- Improves immunoassay and mass spectrometry screening methods
Safety Data Sheets, Certificates of Analyses, and Other Product-Specific Documents
Publications
, TRACEABLE OPIOID MATERIAL®, and TOM Kits® are registered marks of HHS.